12:08:08 EDT Fri 05 Jun 2026
Enter Symbol
or Name
USA
CA



Telescope Innovations Corp. - Common Shares
Symbol TELI
Shares Issued 79,697,569
Close 2026-06-04 C$ 0.90
Market Cap C$ 71,727,812
Recent Sedar+ Documents

ORIGINAL: Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award

2026-06-05 08:02 ET - News Release

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") congratulates its Founder and Chief Technology Officer, Professor Jason Hein, on receiving the 2026 SCI Canada LeSueur Memorial Award from the Society of Chemical Industry ("SCI").

Cannot view this image? Visit: https://images.newsfilecorp.com/files/8923/300261_328197891408ab84_001.jpg

Figure 1. The 2026 LeSeueur Memorial Award Presented to Professor Jason Hein

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8923/300261_328197891408ab84_001full.jpg

Administered by the Society of Chemical Industry, a professional body founded in London in 1881 and incorporated by Royal Charter in 1907, the LeSueur Memorial Award was established in 1955 in honour of Ernest A. LeSueur, a pioneer in Canadian chemical engineering. The award is presented for technical excellence, in either a university or industrial setting in Canada, with a contribution to Canadian industry through chemical creativity and innovation. Past recipients include distinguished leaders from institutions such as the University of British Columbia, the University of Toronto, McMaster University, and the University of Waterloo, as well as senior innovators from organizations including DuPont, Gilead, and Syncrude. The award is presented annually at the SCI Canada Awards Dinner and is among the most respected honours in the Canadian chemical sciences community. Professor Hein, who also serves as Professor of Chemistry at the University of British Columbia, is recognized for his work at the intersection of physical organic chemistry, reaction mechanism, automation, and deployable technology.

The LeSueur Memorial Award follows Professor Hein's receipt of the 2025 R.U. Lemieux Award from the Chemical Institute of Canada, further reflecting the growing recognition of his contributions to chemical research and pharmaceutical manufacturing innovation.

Henry Dubina, Telescope's CEO, commented, "Jason's recognition with the LeSueur Memorial Award is a testament to the caliber of scientific leadership at the heart of Telescope. His ability to bridge fundamental chemistry, AI, and automation is what makes our Self-Driving Lab technology possible. We are proud to have a CTO whose vision continues to earn recognition at this level."

About Telescope Innovations

Telescope Innovations Corp. is a developer of reaction sampling technology, intelligent automation and advanced chemical manufacturing technologies. The Company builds and deploys enabling technologies including reaction sampling systems for real-time analysis, flexible robotic platforms, and artificial intelligence software that improves experimental throughput, efficiency, and data quality. The Company's "Self-Driving Labs" are fully autonomous, physical AI platforms that plan, execute, and analyze experiments far more efficiently than traditional manual approaches. Bio-pharmaceutical, high value specialty chemical, and advanced materials companies utilize Telescope's products and services to accelerate the development and optimization of chemical processes, thereby cutting down time and costs from lab to market. For more information, please visit www.telescopeinnovations.com.

On behalf of the Board,

Telescope Innovations Corp.

Henry Dubina, Chief Executive Officer
E: henry.dubina@telescopeinn.com
T: 778-262-1113

Forward-Looking Information

This press release may contain forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Telescope Innovations to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. These statements relate to future events or future performance, reflect management's current expectations and are based on information currently available to management. A number of factors could cause actual events, performance, or results to differ materially from what is projected in the forward-looking statements, including without limitation: technological risks and uncertainties; market acceptance of Telescope's technology; the Company's ability to retain key personnel; general economic conditions; and other risks detailed in the Company's public filings. The Company does not undertake to update any forward-looking information except in accordance with applicable securities laws.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300261

© 2026 Canjex Publishing Ltd. All rights reserved.